Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. 3-month report Köln, 11.5.2010 (euro adhoc) - november AG - On Schedule november AG continues upswing / publication of consolidated results 1st quarter 2010 reduction of liabilities 3 Mio. EUR restructuring of remaining loan portfolio into predominantly long-term ...
improved operating profits despite reduced consolidated revenues consolidated results virtually break-even with EUR 0.3 mio reduction of liabilities from EUR 9.9 mio to EUR 6.9 mio increase of equity capital from EUR 7.9 mio (2007), EUR 5.6 mio (2008) to EUR 3.8 mio (2009) improved ...
Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. Board of Directors (Appointments and Changes)/Capital measures Köln (euro adhoc) - The capital increase of the november AG, decided on November 11, 2009, has been successfully ...
ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. Consolidation 11.01.2010 november AG (ISIN: DE000A0S9N72) announces the successful negotiation with another ...
ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. Financial Consolidation 07.01.2010 Today, november AG (ISIN: DE000A0Z24E9) succeeded in negotiating another waiver of a substantial loan. On the one hand, one of the ...
ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. 11.11.2009 The Management Board of november Aktiengesellschaft has decided today with the consent of the Supervisory Board to partially use the authorized capital ...
Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. quarterly report/Company Information Cologne (euro adhoc) - Publication of consolidated quarterly report per September 30, 2009 - The operating profit of PROGEN Biotechnik GmbH shows a remarkable increase to TEUR 800 - Consolidated ...
november AG continues economic upturn/ Preliminary results confirm positive trend Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. finances Munic (euro adhoc) - The preliminary results of the 2nd quarter of fiscal year 2009 confirm the upward trend already reported for the 1st ...
ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. 30.04.2009 Erlangen, April 30, 2009 Today, november AG (ISIN: DE000A0S9N72) in cooperation with one of the investors succeeded in restructuring major debts of the ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Spin-offs 02.03.2009 (Erlangen, March 2, 2009) PROGEN Biotechnik GmbH, a wholly-owned subsidiary of november AG, has today concluded a contract with AXIS-SHIELD GmbH, Heidelberg, the Germany ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 11.09.2008 november AG´s management and supervisory board suggest a capital decrease at an extraordinary annual meeting aiming at supporting november AG´s n-going financial restructuring. As ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Contracts 28.07.2008 IBL Gesellschaft für Immunchemie und Immunbiologie mbH, a 100% subsidiary of november AG, Erlangen, is sold to Meddens Diagnistics BV, Amsterdam in an asset deal ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Company Information 23.04.2008 Erlangen, 23rd April 2008. With approval of the Supervisory Board november AG assigns its 51% share of PELAB Biotechnologie GmbH with immediate effect. The compensation of EUR 1,500,000.00 will be payable by ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 14.02.2008 Erlangen, 14 February 2008. November AG´s filing for insolvency has been rejected by the competent local court. Meanwhile Dr. Dirk Zurek has been appointed as november ag's new sole CEO. end of announcement ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 02.01.2008 Prof. Dr. Dr. Dresel has resigned as a member of november AG's Board of Directors. end of announcement euro adhoc ots Originaltext: november AG Im ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 21.12.2007 Erlangen, 21 December 2007. The Erlangen based development and holding company november AG (ISIN DE000A0S9N72) has filed for insolvency today´s evening, 21 December 2007, with the ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 20.12.2007 Erlangen, 20 December 2007. The Hamburg based IBL Gesellschaft für Immunchemie und Immunbiologie mbH, a 100% subsidiary of the Erlangen based development and holding company ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. C.E.O. Interviews 03.12.2007 Erlangen, 3rd December 2007. Dr. Claus Müller has asked the supervisory board of november AG to release him from all duties related to his present office as CEO of the company for health reasons with immediate ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 20.11.2007 Erlangen, 20. November 2007. According to the decision made at the last annual shareholder´s meeting on May 22nd 2007, november AG has successfully completed the capital increase ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 16.11.2007 Erlangen, 16. November 2007. November AG has been notified that BAFIN relieves BIOMED and Dr. Claus Müller from submitting a mandatory offer under section 37 of the german ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 22.05.2007 Erlangen, 22. May 2007. Today´s shareholder´s meeting of november AG has resolved all resolutions which have been proposed by the executive and the supervisory board with the ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Company Information 04.04.2007 Erlangen, 04. April 2007. In order to continue the financial restructuring of november AG i.I., the annual shareholders meeting, taking place on May 22nd, ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. C.E.O. Interviews 28.03.2007 Erlangen, 28 March 2007. On todays scheduled supervisory board-meeting of november AG, a biotech development and investment holding in Erlangen, Germany (ISIN ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 12.03.2007 Erlangen, 12 March 2007. The creditor's meeting of november AG i.l. (ISIN DE0006762909), a biotech development- and investment-holding located in Erlangen, Germany, has - in it's ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 01.12.2006 Erlangen, 01 December 2006. Today, the main insolvency proceedings over the assets of the Erlangen based development and holding company november AG (ISIN DE0006762909) have been ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 30.11.2006 Erlangen, 30. November 2006. The supervisory board of the Erlangen based development and holding company november AG (ISIN DE0006762909) elected Günter Frankenne as its new chairman and Horst Linn as his deputy chairman with immediate ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 09.11.2006 Because of the insolvency filings of the parent and the two subsidiaries identif GmbH and directif GmbH, a record loss is being shown. Erlangen, 9 November 2006. In the first 9 ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 28.09.2006 Erlangen, 28 September 2006. After the Erlangen based development and holding company november AG (ISIN DE0006762909), also its subsidiaries identif GmbH and directif GmbH have filed ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 26.09.2006 Erlangen, 26 September 2006. The Erlangen based development and holding company november AG (ISIN DE0006762909) has filed for insolvency today, 26 September 2006, with the local court ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 04.09.2006 Erlangen, 4 September 2006. The Chief Executive Officer of Erlangen based development and holding company november AG (ISIN DE0006762909), Dr. Wolf M. Bertling, has left november ...